- Home
- ALGS vs TPCS Comparison
ALGS vs TPCS Comparison
Compare ALGS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- TPCS
- Stock Information
- Founded
- ALGS 2018
- TPCS 1956
- Country
- ALGS United States
- TPCS United States
- Employees
- ALGS N/A
- TPCS N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- TPCS Metal Fabrications
- Sector
- ALGS Health Care
- TPCS Industrials
- Exchange
- ALGS Nasdaq
- TPCS Nasdaq
- Market Cap
- ALGS 36.0M
- TPCS 42.6M
- IPO Year
- ALGS 2020
- TPCS N/A
- Fundamental
- Price
- ALGS $7.20
- TPCS $3.56
- Analyst Decision
- ALGS Strong Buy
- TPCS
- Analyst Count
- ALGS 1
- TPCS 0
- Target Price
- ALGS $70.00
- TPCS N/A
- AVG Volume (30 Days)
- ALGS 156.2K
- TPCS 59.4K
- Earning Date
- ALGS 08-05-2025
- TPCS 04-08-2025
- Dividend Yield
- ALGS N/A
- TPCS N/A
- EPS Growth
- ALGS N/A
- TPCS N/A
- EPS
- ALGS N/A
- TPCS N/A
- Revenue
- ALGS $3,270,000.00
- TPCS $33,154,058.00
- Revenue This Year
- ALGS N/A
- TPCS N/A
- Revenue Next Year
- ALGS N/A
- TPCS N/A
- P/E Ratio
- ALGS N/A
- TPCS N/A
- Revenue Growth
- ALGS N/A
- TPCS 8.71
- 52 Week Low
- ALGS $3.76
- TPCS $2.05
- 52 Week High
- ALGS $46.80
- TPCS $4.42
- Technical
- Relative Strength Index (RSI)
- ALGS 62.71
- TPCS 51.99
- Support Level
- ALGS $5.47
- TPCS $3.45
- Resistance Level
- ALGS $6.12
- TPCS $4.00
- Average True Range (ATR)
- ALGS 0.59
- TPCS 0.24
- MACD
- ALGS 0.21
- TPCS -0.08
- Stochastic Oscillator
- ALGS 88.92
- TPCS 11.34
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.